Europe — EMA
Omlyclo (Omalizumab)
Omalizumab, the active ingredient in Omlyclo, is a monoclonal antibody presented as a injection for subcutaneous use. It treats moderate to severe persistent allergic asthma and chronic spontaneous urticaria in patients…
Request sourcing
1
Pack/s
What is Omalizumab?
Omalizumab, the active ingredient in Omlyclo, is a monoclonal antibody presented as a injection for subcutaneous use. It treats moderate to severe persistent allergic asthma and chronic spontaneous urticaria in patients who inadequately respond to standard treatments. GNH USA supplies Omlyclo as a licensed ...
What is Omalizumab used for?
Omlyclo ...
Product details
Drug
Omalizumab
Route
Subcutaneous Use
Manufacturer
Celltrion Healthcare Hungary Kft
Origin
EU
Related products

Xolair 150 mg
Omalizumab · 150 MG
Xolair
POWDER FOR SOLUTION
NOVARTIS PHARMACEUTICALS CANADA INC
CANADA

Xolair 75 mg
Omalizumab · 75 MG
Xolair
SOLUTION
NOVARTIS PHARMACEUTICALS CANADA INC
CANADA

Xolair 150 mg
Omalizumab · 150 MG
Xolair
SOLUTION
NOVARTIS PHARMACEUTICALS CANADA INC
CANADA

Xolair 75 mg
Omalizumab · 75 MG
Xolair
SOLUTION
NOVARTIS PHARMACEUTICALS CANADA INC
CANADA